Ann: Investor Briefings & Webinar Notice, page-63

The problem with a go slow approach is that for every year or even month that goes past it must reduce the value of an IP / Patent.

Now I am no expert but for a BP to consider a partnership or buy out the must take into consideration the length of time that a patent has to run before expiring.

The length of time left on a patent and profit margins would also need to be taken into account when setting the value a BP would pay for a company.

Now this is only from a very quick look at previous announcements but the use of MPL on other diseases using MTOR method, the patent in USA and Japan was obtain back in 2018. Now there maybe other patents that I haven't seen, but if there're the patents they are working to it means 6 years of the 20 years have already gone.

The patents issue is one reason I think that human cancer has been taken off the agenda.
Yes new patents in various locations were also added in 2018/2019 for cancer